SEC Form 4
AngioDynamics, Inc. (ANGO) insider trading
In the 12 months to Nov 1, 2026, 2 ANGO insiders reported open-market sales of $654.7K across 2 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $654.7K
- 2 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
Who traded ANGO, and when
- Sale
ANGO daily close from Nov 3, 2025 to Oct 30, 2026, between $9.70 and $16.13, last $11.99. 2 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Warren Nighan JR., SVP Quality and Regulatory: sold $344.0K across 1 filing, first filed Jul 31, 2026, last Jul 31, 2026. Stephen A. Trowbridge, EVP and CFO: sold $310.7K across 1 filing, first filed Oct 30, 2026, last Oct 30, 2026.
Largest mark · tap a row for others
Warren Nighan JR. · SVP Quality and Regulatory
Sale $344,006
23,370 shares at $14.72 avg
Filed Jul 31, 2026 · traded Jul 30
Close on filing date $14.79
Warren Nighan JR. · SVP Quality and Regulatory
SVP Quality and Regulatory
$344.0K soldStephen A. Trowbridge · EVP and CFO
EVP and CFO
$310.7K soldOpen-market trades
2 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Warren Nighan JR. | SVP Quality and Regulatory | $344.0K | — | 1 | — | |
| Stephen A. Trowbridge | EVP and CFO | $310.7K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Stephen A. Trowbridge EVP and CFO | Sale | 25,335 | $12.26 | $310.7K | 280,461 | |
traded | Warren Nighan JR. SVP Quality and Regulatory | Sale | 23,370 | $14.72 | $344.0K | 64,745 |
GET /stocks/filings/vX/form-4?tickers=ANGO&filing_date.gte=2025-11-01&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ANGO",
"ANGO.V"
],
"issuer_cik": "0001275187",
"owner_cik": "0001624250",
"accession_number": "0001140361-26-041309",
"form_type": "4",
"filing_date": "2026-10-30",
"period_of_report": "2026-10-28",
"issuer_name": "ANGIODYNAMICS INC",
"issuer_trading_symbol": "ANGO",
"owner_name": "Trowbridge Stephen A",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP and CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-28",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1720,
"transaction_price_per_share": 12.17,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 304076,
"transaction_value": 20932.4,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.15 to $12.20, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."
}
]
},
{
"tickers": [
"ANGO",
"ANGO.V"
],
"issuer_cik": "0001275187",
"owner_cik": "0001624250",
"accession_number": "0001140361-26-041309",
"form_type": "4",
"filing_date": "2026-10-30",
"period_of_report": "2026-10-28",
"issuer_name": "ANGIODYNAMICS INC",
"issuer_trading_symbol": "ANGO",
"owner_name": "Trowbridge Stephen A",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP and CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-29",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 23615,
"transaction_price_per_share": 12.27,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 280461,
"transaction_value": 289756.05,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.07 to $12.35 inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 40 records
- Option exercises5 records
- Tax withholding23 records
- Grants and awards12 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has AngioDynamics, Inc.'s CEO sold stock?
No. James C. Clemmer (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is ANGO’s insider data?
These are ANGO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track ANGO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ANGO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.